Observational studyJAMA network open2024

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors.

Sarah Cook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.